Sign in

You're signed outSign in or to get full access.

Martin E. Stein, Jr.

Executive Chairman of the Board at REG
Executive
Board

About Martin E. Stein, Jr.

Executive Chairman of Regency Centers Corporation; age 72; director since 1993; Chairman since 1998; CEO from 1993 (IPO) through 2019; Executive Chairman since January 1, 2020. Education: Washington and Lee University (undergraduate) and MBA from Dartmouth’s Tuck School of Business. External board: FRP Holdings, Inc.; industry leadership includes past Chair of Nareit; member of ULI, ICSC and Real Estate Roundtable . In 2024, Core Operating Earnings per Share were $4.13 (annual incentive key metric) and Company TSR over 2015–2024 outperformed peers by 27% per proxy summary; same-property NOI grew 3.6%, occupancy reached 96.7% .

Past Roles

OrganizationRoleYearsStrategic Impact
Regency Centers (predecessor division)Vice President1976–1981Early leadership in retail real estate operations
Regency Centers (predecessor division)President1981–1993Led division ahead of IPO
Regency Centers CorporationPresident & CEO1993–1998IPO leadership; established public REIT platform
Regency Centers CorporationChief Executive Officer1993–2019Long-tenured CEO driving capital allocation and growth
Regency Centers CorporationChairman of the Board1998–presentBoard leadership; governance oversight
Regency Centers CorporationExecutive Chairman2020–presentStrategic counsel; investment oversight

External Roles

OrganizationRoleYearsStrategic Impact
FRP Holdings, Inc.DirectorCurrentPublic company board experience; real estate exposure
NareitPast ChairmanPastIndustry leadership; policy influence
ULI, ICSC, Real Estate RoundtableMemberCurrent/PastIndustry network; best practices and advocacy

Fixed Compensation

Metric202220232024
Base Salary ($)$500,000 $500,000 $500,000
All Other Compensation ($)$40,554 $40,728 $40,628
Notable Perquisites401(k) $12,200; life insurance $28,428 401(k) $12,200; life insurance $28,428 401(k) $12,200; life insurance $28,428

Director compensation is not paid to employees; as Executive Chairman, he receives no additional director fees .

Performance Compensation

MetricWeightingTargetActualPayout MultipleVesting
Annual Cash Incentive (Executive Chairman)n/a$0 $0 0.00x n/a
Core Operating EPS (Company plan)80% for NEOs (ex-Steins) $4.01 for 1.00x $4.131.50x n/a
Corporate Responsibility (ESG)20% for NEOs (ex-Steins) Achieve progress Achieved1.50x* n/a

*Corporate Responsibility pays at Core EPS multiple when EPS > target; capped at target if EPS below target . Mr. Stein had no annual cash incentive opportunity in 2024 .

Long-term equity design:

  • Performance Share Units (PSUs): Relative TSR vs FTSE Nareit Equity Shopping Centers Index; payout schedule from 0.0x at −20% to 2.0x at +20% cumulative 3-year performance; 2022–2024 performance paid at 70% of target (Regency +15% vs Index +21%) .
  • Restricted shares (“stock rights”): time-based, equal vesting over four years; no stock options used; full-value shares with dividend equivalents vesting with underlying shares .

Grant values and modeling:

  • 2024 restricted share grant value to Mr. Stein: $150,000 (20% of LT equity target); 2024 market-based awards valued via Monte Carlo at $58.36/share using specified capital market assumptions .

Equity Ownership & Alignment

ItemDetail
Total beneficial ownership751,804 shares (includes 178,141 in non-qualified deferred comp plan; 1,000 in Dividend Reinvestment Plan)
Ownership % of outstanding<1% of 181,525,869 shares outstanding
Indirect holdings (shared voting/investment power)110,263 (The Regency Group, Inc.); 325,382 (The Regency Group II and Regency Square II; Stein is GP); 4,000 (Wellhouse Trust); 24,201 (GRATs; Stein trustee)
Shares pledged as collateralNone; company policy prohibits pledging/margin accounts
Hedging policyProhibits hedging/short sales/options trading by officers/directors
Stock ownership guidelinesRequired multiples of salary/retainer; 25% retention of shares received until guideline met (5-year compliance window)
Options outstanding/exercisedNo stock options outstanding; none exercised in 2024
Shares vested in 202433,998 shares; value realized $2,156,181 (includes dividend equivalents)

Outstanding equity awards (as of 12/31/2024):

TypeShares/Units UnvestedMarket/Payout Value ($)
Time-based restricted shares22,563$1,668,083 (at $73.93 close)
PSUs (2023–2025 at target)12,756$943,051
PSUs (2024–2026 at target)9,952$735,751

Vesting schedule detail (time-based awards):

Vest DateShares
Jan 28, 20253,231
Feb 1, 202512,263
Feb 1, 2025 & Feb 1, 2026 (50% each)2,190
Feb 2, 2025, 2026, 2027 (33 1/3%/yr)2,392
Feb 6, 2025–2028 (25%/yr)2,488

Employment Terms

TermProvision
Agreement typeSeverance and change-of-control agreements (auto-renew annually unless 90-day notice)
Severance (no CoC; termination without Cause/for Good Reason)18 months base salary; 150% of average cash bonus (3 prior years); 18 months medical benefits (COBRA-equivalent)
Change-of-control severance (double trigger; within 2 years)24 months base salary; 200% of average cash bonus; 24 months medical benefits; pro-rated current-year target bonus
Equity treatment (no CoC)Time-based awards vest pro-rata; PSUs vest pro-rata based on achievement to date
Equity treatment (post-CoC qualifying termination)Time-based vest in full; PSUs vest at greater of actual-to-date or target; if Company ceases to be public, awards cashed out at FMV with interest
Retirement/death/disabilityImmediate vesting of time-based; PSUs remain eligible if goals achieved; age/service and notice required
ClawbackRobust policies; severance payments subject to recoupment per Board policy and law
Excise tax (4999)“Best net” approach: either pay excise tax or cap payments to avoid tax, whichever is more favorable after-tax
Restrictive covenantsConfidentiality; one-year non-solicit of employees/customers

Estimated cash and equity on hypothetical termination (as of 12/31/2024):

ScenarioSalary+BonusHealth BenefitsEarly Equity VestingTotal
Without Cause/Good Reason (no CoC)$750,000 $41,178 $1,979,884 $2,771,062
Qualifying Retirement/Death/Disability$3,281,493 (assumes target) $3,281,493
Change of Control (double trigger)$1,000,000 $54,904 $2,953,619 $4,008,523

Board Governance

  • Role separation: Executive Chairman (Stein) and CEO (Palmer) roles are split; when Chairman is an employee, Board elects an Independent Lead Director (Blankenship), who leads executive sessions and evaluations of Executive Chairman/CEO .
  • Independence: 9 of 11 director nominees independent; Stein and Palmer are not independent .
  • Committees: Stein serves on the Investment Committee; this committee oversees capital allocation for acquisitions, redevelopments, new developments (met 5 times in 2024) .
  • Attendance: All directors attended at least 75% of Board/committee meetings in 2024 .
  • Employees serving as directors receive no additional director compensation .

Compensation Committee Analysis

  • Composition: Independent directors; Chair: Deirdre J. Evens; consultant: Semler Brossy (independent, no conflicts) .
  • Peer group methodology: REIT leaders sized at ~0.5×–2× REG market cap; 2025 peer group refreshed—adds Macerich and Agree Realty; removes Spirit Realty (acquired), Cousins and Hudson Pacific (size outliers) .
  • Say-on-pay: >96% approval at 2024 meeting; extensive shareholder engagement (78% of ownership engaged in 2024) .

Performance & Track Record

Metric/Highlight2024 Result
Same Property occupancy96.7% (record-high)
Same Property NOI growth3.6% (adjusted)
Core Operating EPS$4.13; short-term incentive payout 1.50×
Capital allocation$250M+ development/redevelopment starts; $90M acquisitions
Capital returnsRepurchased ~3.3M shares for ~$200M at ~$60.48 avg price; dividend increased 5.2% y/y in 4Q24
10-year TSR vs peersOutperformed by 27% (2015–2024)

Director Compensation (for context)

ElementAmount
Annual cash retainer (non-employee directors)$75,000
Lead Director cash retainer$35,000
Committee chair retainers$15,000–$20,000 depending on committee
Committee member retainers$10,000–$15,000 depending on committee
Annual restricted stock grant$125,000; Lead Director additional $10,000

Equity Ownership & Alignment — Upcoming Vesting Dates (Potential Supply Consideration)

  • 2025 vests scheduled: Jan 28 (3,231 shares); Feb 1 (12,263 shares); Feb 2 (tranche 1 of 3: 2,392 shares); Feb 6 (25% tranche: 2,488 shares); plus 50% tranches for Feb 1, 2025 & 2026 (2,190 shares total) .
  • Policy prohibiting hedging/pledging mitigates misalignment risk; no options outstanding reduces repricing risk .

Investment Implications

  • Alignment: Large long-tenured ownership with meaningful indirect holdings; no pledging; stringent anti-hedging—positive alignment signal .
  • Incentive design: Long-term equity heavily tied to relative TSR; historical payouts vary with market performance (e.g., 70% for 2022–2024)—supports pay-for-performance discipline .
  • Cash comp risk: As Executive Chairman, no annual cash bonus; package is salary + equity—lower near-term cash incentive pressure, but 2025 vesting tranches present potential sellable supply if dispositions occur post-vesting (no disclosure of planned sales) .
  • Retention/CoC: Double-trigger CoC with 2.0× salary and 2.0× bonus; robust severance even absent CoC (1.5× salary; 1.5× bonus), plus favorable “best net” excise approach—reduces departure risk but increases CoC economics .
  • Governance: Dual role mitigated by independent Lead Director and majority-independent Board; Stein limited to Investment Committee—reduces independence concerns relative to audit/comp roles .
  • Shareholder support: Strong say-on-pay (>96%) and consistent engagement suggest low governance overhang; peer calibration maintained with consultant oversight .

Notes: All data derived from Regency Centers’ 2025 DEF 14A proxy statement. Citations provided inline.